Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Offering a comprehensive portfolio of generic injectable and infused oncology medicines in the US, we have an exciting pipeline in development, including a range of biosimilars focusing on oncology and autoimmune diseases.
Website: https://www.fresenius-kabi.com/us/products/biosimilars
